Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 27, 2023

SELL
$63.71 - $70.74 $12,614 - $14,006
-198 Reduced 5.51%
3,394 $217,000
Q1 2023

Apr 17, 2023

BUY
$65.71 - $74.53 $11,236 - $12,744
171 Added 5.0%
3,592 $248,000
Q4 2022

Jan 25, 2023

SELL
$68.48 - $81.09 $1,301 - $1,540
-19 Reduced 0.55%
3,421 $0
Q3 2022

Oct 20, 2022

SELL
$0.13 - $76.84 $20 - $12,371
-161 Reduced 4.47%
3,440 $245,000
Q2 2022

Jul 26, 2022

BUY
$72.62 - $79.98 $34,857 - $38,390
480 Added 15.38%
3,601 $277,000
Q1 2022

Apr 18, 2022

BUY
$61.48 - $73.72 $191,879 - $230,080
3,121 New
3,121 $228,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $126B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Colton Groome Financial Advisors, LLC Portfolio

Follow Colton Groome Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Colton Groome Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Colton Groome Financial Advisors, LLC with notifications on news.